Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward.

Our study is the first report on the neuro-oncology clinical trial landscape in the United States and supports the development of strategies to further improve access to these trials. Additionally, attention is needed to identify and modify other factors contributing to lack of completion.